MindMaze Therapeutics expands digital neurorehabilitation platform across US and Global markets

MindMaze scales neurorehab via asynchronous, gamified training (80% of doses) backed by two US CPT reimbursement codes across 13 countries.

• Supply-demand gap: MindMaze targets the mismatch between stroke, spinal cord injury, TBI and Parkinson's patients and the limited number of neurologists/physical therapists available.
• Asynchronous training dominant: Roughly 80% of training doses in deployments are completed asynchronously, without a therapist physically present.

Themes, sentiment and reasons are AI-written paraphrases, checked so they never quote an episode. They may contain errors. Not investment advice. Episodes remain the property of their creators.